In addition to strong earnings, Eli Lilly’s prospects were brightened by encouraging trial results from its obesity-drug competitor Novo Nordisk.

After more than a year of gloomy forecasts for the U.S. economy, some experts have backed off recession predictions. Here’s what financial advisors say.

RBC Capital Markets is praising some companies that experienced the biggest profit surprises due to AI in the second-quarter earnings season.

The firm reiterated its neutral rating on shares, saying the sales drop may continue until a new lower-priced model is introduced in 2025 or 2026.

A GOP-backed effort to make it more difficult to amend the constitution failed ahead of a fall referendum to enshrine abortion rights in Ohio.

Bitcoin rose in opposition with the market after the crypto failed to move more than 1% in either direction for 14 straight days.

Federal prosecutors said Tuesday that they are still planning to charge FTX founder Sam Bankman-Fried with campaign finance violations.

The move comes at a key time for Goldman CEO David Solomon, who has endured criticism over a failed consumer banking effort, his DJ hobby and other missteps.

New members of the Democratic National Convention leadership team reflect the DNC’s commitment to the Biden-Harris campaign.

Companies that offer student loan assistance on top of remote work may be especially appealing to some people.